Premium
Balchem Corporation (BCPC)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-02-11 | Job Leonard Van GunsterenInitié | -814,00 | 145,38k | Sale to Issuer | 177,49 - 178,68 | 10,15k | -7,42% |
| 2026-02-11 | Mr. Martin Luther ReidSenior VP & Chief Supply Chain Officer | -1,20k | 214,46k | Sale to Issuer | 177,49 - 178,68 | 8,14k | -12,86% |
| 2026-02-11 | Mr. Theodore Lee HarrisCEO, President & Chairman | -10,20k | 1,82M | Sale to Issuer | 177,49 - 178,68 | 94,40k | -9,75% |
| 2026-02-11 | Mr. William A. BackusInitié | -935,00 | 166,98k | Sale to Issuer | 177,49 - 178,68 | 7,02k | -11,76% |
| 2026-02-11 | Mr. Frederic BonedSenior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | -1,35k | 241,69k | Sale to Issuer | 177,49 - 178,68 | 3,98k | -25,37% |
| 2026-02-11 | Mr. M. Brent TignorSenior VP & Chief HR Officer | -1,16k | 206,36k | Sale to Issuer | 177,49 - 178,68 | 12,18k | -8,67% |
| 2026-02-11 | Ms. Hatsuki MiyataExec. VP, Chief Legal Officer & Secretary | -1,06k | 188,83k | Sale to Issuer | 177,49 - 178,68 | 4,98k | -17,52% |
| 2026-02-11 | Mr. Carl Martin BengtssonExec. VP, CFO, Treasurer and GM of Animal Nutrition & Health | -2,72k | 485,29k | Sale to Issuer | 177,49 - 178,68 | 29,01k | -8,57% |
| 2026-02-08 | Mr. William A. BackusInitié | -322,00 | 55,76k | Sale to Issuer | 173,16 | 5,80k | -5,26% |
| 2026-02-08 | Job Leonard Van GunsterenInitié | -258,00 | 44,68k | Sale to Issuer | 173,16 | 9,19k | -2,73% |
| 2026-02-08 | Mr. Carl Martin BengtssonExec. VP, CFO, Treasurer and GM of Animal Nutrition & Health | -863,00 | 149,44k | Sale to Issuer | 173,16 | 23,40k | -3,56% |
| 2026-02-08 | Mr. Theodore Lee HarrisCEO, President & Chairman | -3,23k | 558,44k | Sale to Issuer | 173,16 | 78,96k | -3,92% |
| 2026-02-08 | Mr. Martin Luther ReidSenior VP & Chief Supply Chain Officer | -416,00 | 72,03k | Sale to Issuer | 173,16 | 5,47k | -7,07% |
| 2026-02-08 | Mr. Frederic BonedSenior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | -430,00 | 74,46k | Sale to Issuer | 173,16 | 2,70k | -13,76% |
| 2026-02-08 | Mr. M. Brent TignorSenior VP & Chief HR Officer | -373,00 | 64,59k | Sale to Issuer | 173,16 | 10,21k | -3,53% |
| 2026-02-08 | Ms. Hatsuki MiyataExec. VP, Chief Legal Officer & Secretary | -343,00 | 59,39k | Sale to Issuer | 173,16 | 3,33k | -9,33% |
| 2025-12-03 | Mr. David B. FischerIndependent Director | -6,00k | 451,12k | Derivative Exercise and Sale | 74,57 - 153,91 | 7,99k | - |
| 2025-12-03 | Mr. David B. FischerIndependent Director | -2,00k | 308,29k | Vente | 154,15 | 7,99k | -20,02% |
| 2025-12-04 | Job Leonard Van GunsterenInitié | -6,00k | 554,62k | Derivative Exercise and Sale | 60,85 - 153,80 | 9,45k | - |
| 2025-11-11 | Mr. Martin Luther ReidSenior VP & Chief Supply Chain Officer | -1,20k | 185,33k | Vente | 154,44 | 5,08k | -19,12% |
| 2025-10-31 | Mr. Frederic BonedSenior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | -1,09k | 166,43k | Sale to Issuer | 153,39 | 2,33k | -31,77% |
| 2025-07-25 | Ms. Hatsuki MiyataExec. VP, Chief Legal Officer & Secretary | -483,00 | 71,88k | Sale to Issuer | 148,82 | 2,88k | -14,36% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
